Microcap Ledger Nexgel, Inc. $NXGL
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Langhorne, PA
- Fiscal year end
- December 31
- Shares outstanding
- 9,747,663 [10-Q 2026-08-17]
What the company doesAI summary of filing
NexGel manufactures high water content, electron beam cross-linked hydrogel products used in wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company operates as a contract manufacturer supplying gels to third parties who incorporate them into their own products, and also sells branded consumer products directly to consumers under brands including Medagel, Kenkoderm, and Silly George. The company generates revenue from contract manufacturing, consumer product sales, and white label opportunities, and is developing medical devices including NEXDrape and NEXDerm that it intends to license rather than commercialize directly. [10-K 2026-03-31]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $6.34M | −$4.56M | −$2.70M | $1.71M | [10-Q 2026-08-17] |
| FY ended Dec 2025 | $11.42M | −$3.00M | −$1.31M | $317.0K | [10-K 2026-03-31] |
| FY ended Dec 2024 | $8.69M | −$3.28M | −$3.87M | $1.81M | [10-K 2026-03-31] |
- Quarterly cash burn
- −$1.35M
- Cash runway Estimate
- ~3.8 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2025-03-27 | 7,654,037 | [10-K 2025-03-27] |
| 2025-05-13 | 7,654,537 | [10-Q 2025-05-13] |
| 2025-08-12 | 8,067,580 | [10-Q 2025-08-12] |
| 2025-11-12 | 8,143,133 | [10-Q 2025-11-12] |
| 2026-03-31 | 8,475,693 | [10-K 2026-03-31] |
| 2026-04-28 | 8,849,665 | [10-K/A 2026-04-30] |
| 2026-05-13 | 9,131,055 | [10-Q 2026-05-14] |
| 2026-08-14 | 9,747,663 | [10-Q 2026-08-17] |
- Shelf registration
- S-1 filed 2026-08-20; no effectiveness notice found in EDGAR [S-1 2026-08-20]
Listing status
Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-04-24. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-04-24 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-04-24] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-06-23 | Levy Adam R. | sell | 5,000 | $0.59 | [4 2026-06-23] |
| 2026-06-18 | Levy Adam R. | sell | 6,000 | $0.59 | [4 2026-06-23] |
| 2026-06-11 | Levy Adam R. | sell | 3,000 | $0.61 | [4 2026-06-15] |
| 2026-06-08 | Levy Adam R. | sell | 3,000 | $0.55 | [4 2026-06-09] |
| 2026-06-04 | Levy Adam R. | sell | 3,000 | $0.59 | [4 2026-06-09] |
| 2026-06-01 | Levy Adam R. | sell | 2,000 | $0.59 | [4 2026-06-03] |
| 2026-05-29 | Levy Adam R. | sell | 3,000 | $0.60 | [4 2026-05-29] |
| 2026-05-28 | Levy Adam R. | sell | 7,000 | $0.61 | [4 2026-05-29] |
| 2026-05-27 | Levy Adam R. | sell | 3,000 | $0.60 | [4 2026-05-29] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-07 | 8-K | Change to security holder rights; Charter, bylaws or fiscal year change |
| 2026-09-24 | 8-K | Regulation FD disclosure |
| 2026-09-23 | 8-K | Shareholder vote results |
| 2026-08-24 | DEF 14A | Proxy statement |
| 2026-08-21 | 8-K | Director or officer change |
| 2026-08-20 | S-1 | Registration statement |
| 2026-08-17 | 8-K | Results of operations |
| 2026-08-17 | 10-Q | Quarterly report |
| 2026-08-17 | NT 10-Q | Notice of late quarterly report |
| 2026-08-14 | PRE 14A | Proxy statement |
| 2026-08-05 | 8-K | Shareholder vote results |
| 2026-07-29 | 8-K | Director or officer change |
Alerts for $NXGL
Email me when Nexgel, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.